↓ Skip to main content

Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia

Overview of attention for article published in Psychopharmacology, March 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

policy
1 policy source
twitter
3 X users
patent
5 patents
facebook
7 Facebook pages
video
1 YouTube creator

Citations

dimensions_citation
151 Dimensions

Readers on

mendeley
221 Mendeley
Title
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
Published in
Psychopharmacology, March 2006
DOI 10.1007/s00213-006-0343-1
Pubmed ID
Authors

Sebastian Walther, Richard Mahlberg, Uta Eichmann, Dieter Kunz

Abstract

Nighttime agitation occurs frequently in patients with dementia and represents the number one burden on caregivers today. Current treatment options are few and limited due to substantial side effects.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 221 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 <1%
Jamaica 1 <1%
India 1 <1%
United Kingdom 1 <1%
Unknown 216 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 35 16%
Student > Master 24 11%
Student > Ph. D. Student 23 10%
Student > Bachelor 21 10%
Other 16 7%
Other 42 19%
Unknown 60 27%
Readers by discipline Count As %
Medicine and Dentistry 51 23%
Biochemistry, Genetics and Molecular Biology 17 8%
Agricultural and Biological Sciences 17 8%
Neuroscience 17 8%
Psychology 15 7%
Other 39 18%
Unknown 65 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2022.
All research outputs
#3,011,294
of 23,857,313 outputs
Outputs from Psychopharmacology
#750
of 5,450 outputs
Outputs of similar age
#6,688
of 72,879 outputs
Outputs of similar age from Psychopharmacology
#6
of 42 outputs
Altmetric has tracked 23,857,313 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,450 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 72,879 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.